tm logo
LINEARIS
FORMALIZED

on 19 Dec 2023

Last Applicant/ Owned by

LINEARIS LABS INC.

330 Av AvroPointe-Claire

QUÉBEC

CA

H9R5W5

Serial Number

2300060 filed on 19th Dec 2023

Correspondent Address

630, boul. René-Lévesque Ouest20e étageMontréal

QUÉBEC

CA

H3B1S6

LINEARIS

Trademark usage description

providing access to a computer database containing medical information; analyzing clinical trials in the pharmaceutical, biotechnology and life scien Read More

Classification Information


Class [038]
Providing access to a computer database containing medical information;


Classification kind code

12

Class [042]
Analyzing clinical trials in the pharmaceutical, biotechnology and life sciences fields; chemical molecular analysis, product optimization, and clinical trial services to pharmaceutical industries; data automation and data collection using software to evaluate, analyze and collect clinical research data in the field of genomics; data automation and data collection using software to evaluate, analyze and collect clinical research data in the field of proteomics; data automation and data collection using software to evaluate, analyze and collect clinical research data in the field of metabolomics; data automation and data collection using software to evaluate, analyze and collect molecular research data in the field of genomics; data automation and data collection using software to evaluate, analyze and collect molecular research data in the field of proteomics; data automation and data collection using software to evaluate, analyze and collect molecular research data in the field of metabolomics; application service provider featuring application programming interface (API) software for analyzing molecular and clinical data for scientific and medical research; providing temporary use of non-downloadable software for analyzing molecular and clinical data to provide personalized healthcare recommendations; medical laboratory services; platform as a service (PAAS) featuring computer software platforms enabling medical management and collaboration across medical specialties, departments, hospitals and regions; cloud-based platform for searching structured and unstructured data for healthcare analytics; scientific research laboratories for conducting research in the field of cancer; cloud-based platform for searching structured and unstructured data for healthcare analytics; scientific research laboratories for conducting research in the field of cancer; scientific research laboratories for conducting research in the field of diabetes, diabetes prevention and diabetes diagnosis; scientific research laboratories for conducting research in the field of antimicrobial resistance; drug discovery services; providing temporary use of non-downloadable computer graphing software for use in the field of genomics; structural and functional analysis of genomes; analysis in the field of molecular biology; software as a service (SAAS), namely providing computer software for accessing, querying and analyzing information stored in databases, namely data in the field of chemistry and chemical biology experiments; software as a service (SAAS), namely providing computer software for accessing, querying and analyzing information stored in databases, namely data in the pharmaceutical, biotechnology and life sciences fields; development of pharmaceutical preparations and medicines; research and development of vaccines and medicines; drug discovery services; software as a service (saas) services in the field of software for reporting data in medical records and medication dispensing systems; software as a service (saas) provided for the diagnosis, monitoring and treatment of medical and health information; testing and analysis of blood plasma, red blood cells, white blood cells, blood platelets, urine or other biological specimens for scientific research purposes; Analysing of water to measure and quantify molecules of interest for health purpose, quality control, scientific research, educational and commercial purpose.


Classification kind code

12

Class [044]
Providing analysis, evaluation, and reporting of cancer test results to help healthcare professionals determine a patient's clinical diagnosis; providing analysis, evaluation, and reporting of diabetes test results to help healthcare professionals determine a patient's clinical diagnosis; providing analysis, evaluation, and reporting of antimicrobial resistance test results to help healthcare professionals determine a patient's clinical diagnosis; providing analysis, evaluation, and reporting of test results to help healthcare professionals determine a patient's clinical diagnosis; providing medical information in the treatment and prevention of metabolic diseases and disorders; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; providing cancer screening services; diabetes screening services; medical screening services relating to cardiovascular disease; medical screening services relating to metabolomic diseases; providing information in the field of general health and wellness via a website; providing information relating to health and wellness, namely, diabetes; genomic medical analysis services for cancer; proteomic and metabolomics medical analysis services for diabetes and antimicrobial resistance, diagnosis and treatment; medical screening; providing information relating to the preparation and dispensing of medications; pharmaceutical and drug review services of others; medical analysis services for diagnostic and treatment purposes provided by medical laboratories using diagnostic biomarkers for use in assessment of genomic, proteomic and metabolomics analysis for scientific, education and clinical use; remote monitoring of medical data for medical diagnosis and treatment; analysis and processing of blood plasma, stem cells, red blood cells, white blood cells, blood platelets and urine being medical services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories.


Classification kind code

12

Mark Details


Serial Number

2300060

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 287
on 04th Jan 2024
Pre-Assessment Letter Sent
Submitted for opposition 30
on 19th Dec 2023
Filed
Submitted for opposition 1
on 19th Dec 2023
Created
Submitted for opposition 31
on 19th Dec 2023
Formalized